Hematologic malignancies
Read Online
Share

Hematologic malignancies acute leukemias

  • 916 Want to read
  • ·
  • 17 Currently reading

Published by Springer in Berlin, New York .
Written in English

Subjects:

  • Precursor Cell Lymphoblastic Leukemia-Lymphoma,
  • Leukemia, Myeloid, Acute

Book details:

Edition Notes

Other titlesAcute leukemias
ContributionsEstey, E. H., Faderl, S. H., Kantarjian, Hagop, 1952-
The Physical Object
Paginationx, 294 p.
Number of Pages294
ID Numbers
Open LibraryOL22268929M
ISBN 103540723021
ISBN 109783540723028

Download Hematologic malignancies

PDF EPUB FB2 MOBI RTF

Hematologic Malignancies in Adults gives you comprehensive information on treatments, complications, and toxicity management for your everyday practice. The book focuses on the management of disease-related manifestations and treatment-related side effects and toxicities. This reference book discusses hematologic malignancies in detail including pathophysiology, clinical manifestations, diagnosis, and treatment. There are 14 chapters in total, followed by appendices and the index. The first of the 14 chapters highlights the advances in hematologic malignancies that have been made over the past 10 by: 2. @article{osti_, title = {Hematologic malignancies}, author = {Hoogstraten, B}, abstractNote = {The principle aim of this book is to give practical guidelines to the modern treatment of the six important hematologic malignancies. Topics considered include the treatment of the chronic leukemias; acute leukemia in adults; the myeloproliferative disorders: polycythemia vera, essential. Hematologic malignancies are generally diseases of the elderly, as the median age for most of these diseases hovers around 65–70 years of age. Acute myeloid leukemia (AML), the most common indication for allogeneic transplant, is an important example. Compared to adults 20–24 years of age, the incidence of AML is almost threefold higher for.

Hematologic Malignancies in Adults gives you comprehensive information on treatments, complications, and toxicity management for your everyday practice. The book focuses on the management of More than years since Thomas Hodgkin identified the first hematologic malignancy, nurses are still learning the best ways to treat patients with these Ratings: 0. Handbook of Hematologic Malignancies provides a unique, practical, and concise guide focused on the must-know points of diagnosis, prognosis, therapeutic management, and cutting edge clinical trial opportunities for each hematologic malignancy. With an ever-increasing growth of evidence and a significant expansion of available treatmentFile Size: KB. The book Advances in Hematologic Malignancies presents new knowledge of cellular disease processes, molecular pathology, and cytogenetic, epigenetic, and genomic changes that have influenced the current outlook toward hematological malignancies. This book provides a unique, practical, and concise guide that is focused on the must-know points of diagnosis, prognosis, therapeutic management, and Author: Gamal Abdul Hamid. Genomic analysis has greatly influenced the diagnosis and clinical management of patients affected by diverse forms of hematologic malignancies. Here, we review how genetic alterations define subclasses of patients with acute leukemias, myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPNs), non-Hodgkin lymphomas, and classical Cited by:

ic malignancies include a very large number of genetically diverse diseases (Lichtman, ). To provide specialized care for patients with he-matologic malignancies, nurses must keep pace with advances in medicine and science. The pur - pose of this book is to provide a detailed review of these complex malignancies. The context for the review. Introduction. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a powerful approach for treating hematologic malignancies (1, 2).This approach involves infusing patients with blood-forming stem cells from a genetically similar but not identical (i.e. allogeneic) donor, with the goal of eradicating the patient’s malignancy while re-establishing by:   Hematologic malignancies comprise only approximately 10% of all cancers, but the incidence of these malignancies is increasing, even as the incidence of many nonhematologic cancers (eg, lung and breast cancer) is decreasing. The incidence is expected to Author: Paulette Mehta. This series of professional books provides in-depth information on all aspects of the diagnosis and treatment of different hematologic cancers, including clinical evaluation, imaging diagnosis, staging, current treatment strategies, novel targeted approaches, and evaluation of treatment response.